| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,592 |
9,320 |
$729K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,499 |
1,467 |
$161K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
852 |
851 |
$89K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,686 |
1,617 |
$86K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,495 |
1,466 |
$77K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
600 |
595 |
$32K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
321 |
321 |
$23K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
808 |
800 |
$17K |
| 99051 |
|
1,674 |
1,665 |
$12K |
| 95117 |
|
845 |
396 |
$9K |
| 92567 |
|
581 |
579 |
$8K |
| 99441 |
|
140 |
140 |
$7K |
| 11721 |
|
213 |
212 |
$7K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
38 |
38 |
$6K |
| 92557 |
|
119 |
118 |
$4K |
| 95115 |
|
232 |
132 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
533 |
533 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
84 |
84 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
51 |
50 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
37 |
37 |
$542.05 |
| 92555 |
|
12 |
12 |
$130.32 |
| 99000 |
|
47 |
46 |
$0.00 |